BRIEF-Coya Therapeutics Receives Clinical Trial Application Acceptance From Health Canada

Reuters
Dec 23, 2025
BRIEF-Coya <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Receives Clinical Trial Application Acceptance From Health Canada

Dec 23 (Reuters) - Coya Therapeutics Inc COYA.O:

  • COYA THERAPEUTICS RECEIVES CLINICAL TRIAL APPLICATION $(CTA)$ ACCEPTANCE FROM HEALTH CANADA TO PROCEED WITH THE COYA 302 ALSTARS TRIAL FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)

  • COYA THERAPEUTICS INC - ALSTARS TRIAL UNDERWAY IN US AND CANADA

Source text: ID:nBw9n9x0Pa

Further company coverage: COYA.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10